Ticker Details
Arvinas, Inc.
IPO Date:	September 24, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$770.05M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.02 | 2.92%
Avg Daily Range (30 D):	$0.34 | 2.74%
Avg Daily Range (90 D):	$0.31 | 2.69%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	1.3M

Trade Size
Avg Trade Size (Sh.):	73
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	3,240
Avg Institutional Trade:	$2.18M
Avg Institutional Trade (30 D):	$1.58M
Avg Institutional Trade (90 D):	$1.79M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.57M
Avg Closing Trade (30 D):	$1.43M
Avg Closing Trade (90 D):	$1.85M
Avg Closing Volume:	91.35K

News

Jan 22, 2026 @ 4:12 AM New nanoparticle technology offers hope for hard-t... Source: Not Specified

Dec 6, 2025 @ 1:05 PM Arvinas Presents Preclinical Data Supporting Mecha... Source: Arvinas, Inc.

Nov 24, 2025 @ 12:00 PM Arvinas Announces Data Presentations from the Vepd... Source: Arvinas, Inc.

Nov 3, 2025 @ 9:00 PM Arvinas to Present Preclinical Data for ARV-393 at... Source: Arvinas, Inc.

Oct 24, 2025 @ 8:00 PM Arvinas Presents Preclinical Data for ARV-806 Demo... Source: Arvinas, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.48	$-.84
Diluted EPS		$-.48	$-.84
Revenue		$41.9M	$22.4M
Gross Profit
Net Income / Loss		$-35.1M	$-61.2M
Operating Income / Loss		$-43.8M	$-71.5M
Cost of Revenue
Net Cash Flow		$-13.4M	$33.9M
PE Ratio